Moderna is in talks with U.S. regulators to expand the size of an ongoing trial testing its COVID-19 vaccines in children aged between 5 and 11, the drugmaker said on Monday.
via CBC | Top Stories NewsMonday, 26 July 2021
Moderna in talks with U.S. regulators to expand COVID-19 vaccine pediatric study
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment